There is an urgent need for therapies to treat and prevent devastating viral diseases in immunocompromised patients who have limited or no treatment options.
We develop revolutionary, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies to treat patients fighting viral infections.
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?